角膜移植术后角膜白细胞密度的纵向变化
一项前瞻性研究使用活体共聚焦显微镜(IVCM)评估角膜移植术前及术后1周、1、3、12个月角膜白细胞密度变化,并分析其与移植排斥风险的关系。结果显示白细胞密度随诊断、血管化程度和术后时间变化,术后12个月有排斥反应眼的白细胞密度几乎为无排斥眼的两倍(79.0 vs 39.8 cells/mm2),SBNP-TCLD >63.5 cells/mm2 与1年和4年内排斥风险增高相关。
要点
- 角膜移植术后白细胞密度随诊断、血管化程度和术后时间变化。
- 有排斥反应眼12个月白细胞密度几乎为无排斥眼的两倍。
- SBNP-TCLD >63.5 cells/mm2 与1年和4年内排斥风险增高相关。
核心结论
- 角膜白细胞密度随角膜诊断、血管化程度和移植术后时间变化。
- 局部激素治疗与白细胞密度降低及移植排斥风险降低相关。
- 较高的内皮白细胞密度与既往或后续排斥反应显著相关。
- IVCM测量白细胞密度可能有助于识别有排斥风险的移植眼。
研究设计与样本
- 前瞻性研究,使用活体共聚焦显微镜(IVCM)对移植前及移植后1周、1、3、12个月角膜成像。
- 分析白细胞密度与诊断、血管化、角膜移植类型、局部激素和免疫抑制治疗、移植排斥及移植失败(术后4年内)的关系。
主要发现
- SBNP-TCLD随诊断(p<0.001)、术后时间(p<0.001)、血管化程度(p=0.001)及停用局部激素眼的排斥发作(p=0.01)而变化。
- 移植前有炎症的眼SBNP-TCLD最高。
- 有排斥发作眼12个月平均SBNP-TCLD为79.0 cells/mm2,无排斥眼为39.8 cells/mm2。
- SBNP-TCLD >63.5 cells/mm2 与1年内(p=0.04)和4年内(p=0.007)排斥风险增高相关。
- 供体内皮白细胞密度变化在穿透性角膜移植与深板层角膜移植间显著不同(p<0.01),在观察到排斥发作的眼亦显著不同(p<0.001)。
关键数值与推荐
- SBNP-TCLD >63.5 cells/mm2 与1年内排斥风险增高相关(p=0.04)。
- SBNP-TCLD >63.5 cells/mm2 与4年内排斥风险增高相关(p=0.007)。
- 有排斥发作眼12个月平均SBNP-TCLD为79.0 cells/mm2,无排斥眼为39.8 cells/mm2。
临床怎么用
- IVCM测量的角膜白细胞密度可能用于识别有排斥风险的移植眼。
- 局部激素治疗与白细胞密度降低及排斥风险降低相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To prospectively evaluate the changes in corneal leucocyte density with in vivo confocal microscopy (IVCM) following transplantation and to determine if leucocyte density post-transplant is an indicator of graft rejection risk. METHODS: IVCM imaging of cornea pre-transplant and post-transplant at 1 week, 1, 3 and 12 months. The changes in leucocyte density associated with diagnosis, vascularisation, type of keratoplasty, topical steroid and immunosuppression treatment, allograft rejection and failure within 4 years post-transplant were analysed. RESULTS: Sub-basal nerve plexus total central leucocyte density (SBNP-TCLD) varied with diagnosis (p<0.001), interval post-transplant (p<0.001), degree of vascularisation (p=0.001) and rejection episodes in eyes off topical steroid (p=0.01). The highest SBNP-TCLD was found in eyes with inflammation pre-transplant. Mean 12-month SBNP-TCLD in eyes which had rejection episodes was almost double that in eyes which did not (79.0 and 39.8 cells/mm2, respectively). SBNP-TCLD >63.5 cells/mm2 was associated with a higher risk of rejection within 1 year (p=0.04) and 4 years (p=0.007). Changes in leucocyte density on the donor endothelium significantly differed between penetrating keratoplasty and deep anterior lamellar keratoplasty grafts (p<0.01) and in those in which rejection episodes were observed (p<0.001). CONCLUSIONS: Leucocyte density varies with corneal diagnosis, extent of vascularisation and interval post-transplant. Topical steroid treatment is associated with reduced leucocyte density and risk of graft rejection. Higher endothelium leucocyte density correlates significantly with previous or subsequent rejection episodes. Leucocyte density measurement by IVCM may be useful in identifying transplants at risk of rejection.
引用
- Hau S, Clarke B, Thaung C, et al. Longitudinal changes in corneal leucocyte density in vivo following transplantation. Br J Ophthalmol. 2018. PMID: 30355719. doi:10.1136/bjophthalmol-2018-312386
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。